Cargando…
The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
In most cases, the atypical hemolytic uremic syndrome (aHUS) is a genetic disease resulting from defects in the regulation of the complement cascade, which conditions the development of thrombotic microangiopathy. Clinically, aHUS presents with acute kidney injury, thrombocytopenia, and microangiopa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270077/ https://www.ncbi.nlm.nih.gov/pubmed/35812637 http://dx.doi.org/10.7759/cureus.25743 |